Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 388

Oncopia accepts Roivant offer

Roivant Sciences has acquired University of Michigan spinout Oncopia Therapeutics.

Dec 6, 2020

Central Garden and Pet sets up $20m fund

Jon Balousek is heading up the garden and pet supplies retailer's newly formed Central Ventures subsidiary.

Dec 5, 2020

Poland's Totalizator set ups fund with FFVC

Totalizator Sportowy set up the $26.8m fund with the support of state-backed fund of funds PFR Ventures and the National Centre for Research and Development

Dec 5, 2020

Corporate venturing deal net: 30 November-4 December 2020

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Dec 4, 2020

Starcity to house Ollie acquisition

Starcity’s acquisition of Aviva-backed Ollie will create what is set to be one of the largest co-living developers and operators worldwide.

Dec 4, 2020

Versatile fits $20m into series A

Robert Bosch Venture Capital and Conductive Ventures were among the investors in a round that will help the construction data technology developer enhance its product.

Dec 4, 2020

Helbiz drives Skip acquisition

The Toyota-backed scooter sharing service is set to be purchased by rival Helbiz, where it will continue to operate under its present brand.

Dec 4, 2020

UA accommodates bioscience incubator

UA's Center for Innovation has opened its third incubator in Oro Valley with a focus on nurturing local bioscience businesses.

Dec 4, 2020

Silverback pounds through $242m IPO

Celgene and Bristol-Myers Squibb have scored exits as the oncology drug developer priced an upsized offering above its range.

Dec 4, 2020

Everlywell gets $175m results from series D

The Chernin Group-backed series D round valued the medical test provider at $1.3bn while pushing its total funding past $250m.

Dec 4, 2020
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here